We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ThromboGenics Licenses Innovative Technology from Eleven Biotherapeutics

News   Jul 05, 2013

 
ThromboGenics Licenses Innovative Technology from Eleven Biotherapeutics
 
 
Advertisement
 

RELATED ARTICLES

Antibodies Can Be Made Rapidly in Chicken Cells

News

Scientists have developed a system that can generate human antibodies against various antigens faster than existing methods.

READ MORE

Antibody Designed To Identify Toxic Particles That Destroy Healthy Brain in Alzheimer’s Disease

News

Researchers have discovered a way to design an antibody that can identify the toxic particles that destroy healthy brain cells.

READ MORE

Converting Autoimmunity Drugs Into Powerful Anticancer Treatments

News

A team from the University of Southampton has discovered a way to transform antibody drugs previously developed to treat autoimmunity into antibodies with powerful anti-cancer activity through a simple molecular “switch”.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE